Brain Stimulation May Help Reduce Hard-To-Control Seizures

What was studied

This paper was a systematic review of studies on two neuromodulation treatments for drug-resistant epilepsy: transcranial magnetic stimulation (TMS) and vagus nerve stimulation (VNS). The authors searched several databases for studies published from 1995 to 2024 and included 36 studies.

The included studies were a mix of randomized controlled trials, observational studies, and retrospective analyses. The review’s primary outcome was seizure recurrence, and the secondary outcomes were adverse events. The abstract does not clearly say how many total patients were included, their ages, or what types of epilepsy they had.

What they found

The review reports that approximately 47% of patients treated with TMS or VNS had a mean seizure reduction of more than 50%. It also says that in several institutional studies, more than 60% of patients showed significant improvement in seizure control. Overall, the authors conclude that both TMS and VNS show promise for improving seizure control in people with drug-resistant epilepsy and may potentially enhance quality of life and reduce seizure frequency. The review also considered adverse events, but the abstract does not give details about what side effects occurred or how often.

Limits of the evidence

Because this is a review of many different studies, the results depend on the quality of those studies. The included research was mixed in design, and the abstract does not explain how TMS and VNS compared with each other, how much benefit was seen for each treatment separately, or whether results were consistent across age groups and epilepsy types. The abstract also does not report the total number of patients, detailed safety findings, or how long benefits lasted. This means the review suggests possible benefit, but it does not show that these treatments will work the same way for every patient.

For families and caregivers

For families dealing with seizures that do not improve enough with medicine, this review suggests that TMS and VNS are treatment options that may help some people have better seizure control. That may be encouraging, especially when standard medicines have not worked well.

At the same time, the abstract does not give enough detail to know which patients are most likely to benefit, how safe each treatment is in practice, or how they compare with other options. Families may want to ask an epilepsy specialist how these treatments fit into the full care plan, including expected benefits, risks, and whether the person is a candidate for one of them.

What to watch next

Future clinical trials with larger, well-designed studies could help clarify results for TMS and VNS separately, provide more detailed safety information, and follow patients over time.

Terms in this summary

drug-resistant epilepsy

Epilepsy in which seizures are not controlled well enough despite trying appropriate seizure medicines.

neuromodulation

Treatment that changes nerve activity using electrical or magnetic stimulation.

transcranial magnetic stimulation (TMS)

A treatment that uses magnetic pulses applied outside the head to affect brain activity.

vagus nerve stimulation (VNS)

A treatment that sends regular electrical signals to the vagus nerve, usually through an implanted device.

systematic review

A study that collects and summarizes results from many earlier studies using a planned search method.

randomized controlled trial

A study in which people are assigned by chance to different treatments to compare results more fairly.

retrospective analysis

A study that looks back at existing medical records or past data.

adverse events

Side effects or unwanted problems that happen during treatment.